James Leone Greene

Anaconda Biomed SL manufactures healthcare devices. It develops catheters for mechanical thrombectomies. The company was founded by Marc Ribo and Ofir Arad and is headquartered in Barcelona, Spain.

Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy.

CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France.

Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland.

Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland.

STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain.

Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.

EBAMed SA develops solutions for non-invasive and automated treatment of heart arrhythmias. The company was founded by Adriano Garonna and Leo Giovanni and is headquartered in Geneva, Switzerland.

EFI Lake Geneva Ventures ICAV (EFI Lake Geneva Ventures) is a venture capital firm founded in 2020 by Toby Main and Sandy Koifman. The firm is headquartered in Geneva, Switzerland.

Cardiovascular Lab SpA provides health care services. The firm is a bridge between great ideas from physicians and international capital. The company was founded in 2016 and is headquartered in Turin, Italy.

Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland.

Teledyne LeCroy, Inc. provides oscilloscopes and protocol analyzers. Its products include oscilloscopes, protocol analysers, waveform generators, logic analyzers, optical modulation analyzer, and signal integrity studio. The company was founded by Walter LeCroy in 1964 and is headquartered in Chestnut Ridge, NY.

Acrostak Corp. is a Swiss company that specializes in medical devices for interventional cardiology. The private company is based in Geneva, Switzerland. The company's focus is on chronic total occlusion and they offer PTCA balloons and percutaneous coronary intervention devices.

Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland.

IGEA SpA is a holding company, which engages in the provision of clinical biophysics services. It develops orthopedic medical devices and oncological biophysics for the treatment of tumors. The company was founded by Ruggero Cadossi and Donata Marazzi in 1980 and is headquartered in Carpi, Italy.

D-Eye SRL design and manufacture mobile sensing and examination devices, along with companion applications. It enables mass health screenings and data collection to improve access to vital health examination services. The firm also develops cloud-based Platform-as-a-Service (PaaS) systems that will enable telehealth applications, and aggregate and analyze health screening data to provide insight into individual conditions as well as trends across patient populations. The company was founded by Andrea Russo in 2014 and it is headquartered in Padua, Italy.

Atricath SpA is a holding company, which engages in the research and development of technology for the treatment of atrial fibrillation. The company was founded by Enrico Perfler and is headquartered in Milan, Italy.

Newronika SRL manufactures medical and electro-medical equipment and appliances. It offers new adaptive deep brain stimulation systems for movement disorders (DBS); methods and devices for transcranial direct current stimulation (tDCS) represent the non-invasive neuromodulation activity. The company was founded by Priori Alberto and Lorenzo Rossi and is headquartered in Milan, Italy.

Cuebiq, Inc. develops a mobile user engagement software platform. The company offers AudienceQ, VisitQ, InsightQ Audience, InsightQ Places and data monetization. The firm uses data intelligence platform to provide geo-behavioral insights and offline location analytics, geo-behavioral audiences for cross-platform ad targeting, and offline attribution analysis by observing and analyzing time spent by users at points of interest across the globe. The company was founded by Andrea Cozzi, Antonio Tomarchio, Filippo Privitera, Walter Ferrara, and William Nespoli and it is headquartered in New York, NY.

Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.

Angiodroid SRL engages in the development and commercialization of medical devices. The firm specializes in the hemodynamics, vascular surgery and interventional radiology. It offers ANGIODROID CO2 injector, a carbon dioxide injector for peripheral interventional angiography and ANGIODROID CO2 single kit use for the injection of CO2 during an angiographic procedure. The company was founded by Sebastiano Zannoli and Samuele Zannoli in 2013 and is headquartered in San Lazzaro di Savena, Italy.

Beintoo SpA develops and markets mobile engagement software solutions. The firm specializes in the design and operation of a customer engagement platform, offering loyalty programs to mobile users. The company was founded by Andrea Cozzi, Antonio Tomarchio, Walter Ferrara, William Nespoli, and Filippo Privitera on January 20, 2011 and is headquartered in Milan, Italy.

IGEA '98 Srl provides real estate services. The private company is based in Rome, Italy.

EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.

e-EyeCare GmbH operates an online ophthalmology portal. The private company is based in Erlangen, Germany.

Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain.

LiftT SpA (LiftT) is a venture capital firm founded in 2019. The firm is headquartered in Turin, Italy.

Bio4Dreams SpA (Bio4dreams) is a venture capital firm founded in 2017 by Pietro Conti, Laura Iris Ferro, Elisabetta Borello and Cusi Daniele. The firm is headquartered in Milan, Italy.

Value Italy SGR SpA (Value Italy) is an independent private equity firm founded in 2001. The firm is headquartered in Florence, Italy.

Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid.

AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then.